Joseph A Lewnard1, Noga Givon-Lavi2, Amit Huppert3, Melinda M Pettigrew1, Gili Regev-Yochay4, Ron Dagan2, Daniel M Weinberger1. 1. Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, Connecticut. 2. Pediatric Infectious Disease Unit, Soroka University Medical Center Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva. 3. Section of Biostatistics. 4. Section of Infectious Disease Epidemiology, Gertner Institute for Epidemiology and Health Policy Research Infectious Disease Unit, Sheba Medical Center, Ramat-Gan, Israel.
Abstract
BACKGROUND: Cocolonization by Streptococcus pneumoniae and Haemophilus influenzae among children has been noted in numerous studies, as has an inverse relationship involving colonization with these species and Staphylococcus aureus. Interactions among these pathogens could mediate unanticipated outcomes of clinical interventions, including changes in H. influenzae and S. aureus disease incidence following pneumococcal vaccine introduction. However, it remains unclear whether cocolonization patterns represent true interspecies interactions or whether they result from confounding factors. METHODS: We investigated polymicrobial carriage using longitudinal data from 369 Bedouin children and 400 Jewish children in Israel who were enrolled in a 7-valent pneumococcal conjugate vaccine (PCV7) trial. Children were swabbed 10 times between 2 and 30 months of age. RESULTS: The pathogens followed distinct age and seasonal distributions, but polymicrobial carriage associations persisted after controlling for these and other confounding factors. Receipt of PCV7 resulted in pneumococcal serotype replacement but did not influence total carriage of S. pneumoniae, H. influenzae, or S. aureus. CONCLUSIONS: The fact that S. pneumoniae, H. influenzae, and S. aureus polymicrobial carriage patterns do not result from confounding by age and season supports the idea of active interspecies interactions. However, pneumococcal serotype replacement may prevent changes in H. influenzae and S. aureus carriage among PCV7 recipients.
RCT Entities:
BACKGROUND: Cocolonization by Streptococcus pneumoniae and Haemophilus influenzae among children has been noted in numerous studies, as has an inverse relationship involving colonization with these species and Staphylococcus aureus. Interactions among these pathogens could mediate unanticipated outcomes of clinical interventions, including changes in H. influenzae and S. aureus disease incidence following pneumococcal vaccine introduction. However, it remains unclear whether cocolonization patterns represent true interspecies interactions or whether they result from confounding factors. METHODS: We investigated polymicrobial carriage using longitudinal data from 369 Bedouin children and 400 Jewish children in Israel who were enrolled in a 7-valent pneumococcal conjugate vaccine (PCV7) trial. Children were swabbed 10 times between 2 and 30 months of age. RESULTS: The pathogens followed distinct age and seasonal distributions, but polymicrobial carriage associations persisted after controlling for these and other confounding factors. Receipt of PCV7 resulted in pneumococcal serotype replacement but did not influence total carriage of S. pneumoniae, H. influenzae, or S. aureus. CONCLUSIONS: The fact that S. pneumoniae, H. influenzae, and S. aureus polymicrobial carriage patterns do not result from confounding by age and season supports the idea of active interspecies interactions. However, pneumococcal serotype replacement may prevent changes in H. influenzae and S. aureus carriage among PCV7 recipients.
Authors: Gili Regev-Yochay; Debby Bogaert; Richard Malley; Peter W M Hermans; Reinier H Veenhoven; Elisabeth A M Sanders; Marc Lipsitch; Ethan Rubinstein Journal: Clin Infect Dis Date: 2008-07-15 Impact factor: 9.079
Authors: Lisa M McNally; Prakash M Jeena; Kavitha Gajee; A Willem Sturm; Andrew M Tomkins; Hoosen M Coovadia; David Goldblatt Journal: J Infect Dis Date: 2006-06-30 Impact factor: 5.226
Authors: Heiman F L Wertheim; Damian C Melles; Margreet C Vos; Willem van Leeuwen; Alex van Belkum; Henri A Verbrugh; Jan L Nouwen Journal: Lancet Infect Dis Date: 2005-12 Impact factor: 25.071
Authors: Shabir A Madhi; Peter Adrian; Locadiah Kuwanda; Clare Cutland; Werner C Albrich; Keith P Klugman Journal: J Infect Dis Date: 2007-10-25 Impact factor: 5.226
Authors: Ron Dagan; Galia Barkai; Noga Givon-Lavi; Amir Z Sharf; Daniel Vardy; Ted Cohen; Marc Lipsitch; David Greenberg Journal: J Infect Dis Date: 2008-04-15 Impact factor: 5.226
Authors: Robert Cohen; Corinne Levy; Franck Thollot; France de La Rocque; Marc Koskas; Eric Bonnet; Bernard Fritzell; Emmanuelle Varon Journal: Clin Infect Dis Date: 2007-12-15 Impact factor: 9.079
Authors: Florence Datta; Thomas Erb; Ulrich Heininger; Alain Gervaix; Urs B Schaad; Christoph Berger; Bernard Vaudaux; Christoph Aebi; Michael Hitzler; Christian Kind; Hanspeter E Gnehm; Reno Frei Journal: Clin Infect Dis Date: 2008-10-01 Impact factor: 9.079
Authors: Krzysztof Trzciński; Claudette M Thompson; Amit Srivastava; Alan Basset; Richard Malley; Marc Lipsitch Journal: Infect Immun Date: 2008-04-07 Impact factor: 3.441
Authors: Joseph A Lewnard; Paula A Tähtinen; Miia K Laine; Laura Lindholm; Jari Jalava; Pentti Huovinen; Marc Lipsitch; Aino Ruohola Journal: J Infect Dis Date: 2018-09-22 Impact factor: 5.226
Authors: Joseph A Lewnard; Amit Huppert; Noga Givon-Lavi; Melinda M Pettigrew; Gili Regev-Yochay; Ron Dagan; Daniel M Weinberger Journal: J Infect Dis Date: 2016-08-17 Impact factor: 5.226
Authors: Joseph A Lewnard; Noga Givon-Lavi; Daniel M Weinberger; Marc Lipsitch; Ron Dagan Journal: Clin Infect Dis Date: 2017-11-13 Impact factor: 9.079
Authors: Daniel Eibach; Michael Nagel; Benedikt Hogan; Clinton Azuure; Ralf Krumkamp; Denise Dekker; Mike Gajdiss; Melanie Brunke; Nimako Sarpong; Ellis Owusu-Dabo; Jürgen May Journal: PLoS One Date: 2017-01-20 Impact factor: 3.240
Authors: Christopher J Greene; Laura R Marks; John C Hu; Ryan Reddinger; Lorrie Mandell; Hazeline Roche-Hakansson; Natalie D King-Lyons; Terry D Connell; Anders P Hakansson Journal: Infect Immun Date: 2016-05-24 Impact factor: 3.441